Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calblock tablet postmarketing clinical study in essential hypertension with type 2 diabetes
jRCT1080220028Phase 4
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Azelnidipine and Temocapril in essential hypertension and type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
AzelnidipineTemocapril
03
Conditions
essential hypertensiontype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080220028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220028.